Share on StockTwits

Shares of Arrowhead Research Corp (NASDAQ:ARWR) were the recipient of a large increase in short interest in August. As of August 15th, there was short interest totalling 11,497,209 shares, an increase of 64.0% from the July 31st total of 7,009,913 shares, American Banking reports. Based on an average trading volume of 3,998,283 shares, the days-to-cover ratio is presently 2.9 days. Approximately 22.4% of the company’s stock are short sold.

A number of analysts have recently weighed in on ARWR shares. Analysts at Deutsche Bank reiterated a “buy” rating on shares of Arrowhead Research Corp in a research note on Wednesday, August 13th. Analysts at Jefferies Group raised their price target on shares of Arrowhead Research Corp from $29.00 to $30.00 in a research note on Friday, June 20th. They now have a “buy” rating on the stock. Five investment analysts have rated the stock with a buy rating, Arrowhead Research Corp has an average rating of “Buy” and an average price target of $24.29.

Shares of Arrowhead Research Corp (NASDAQ:ARWR) opened at 14.14 on Friday. Arrowhead Research Corp has a 1-year low of $4.10 and a 1-year high of $27.63. The stock has a 50-day moving average of $12.60 and a 200-day moving average of $14.96. The company’s market cap is $748.1 million.

Arrowhead Research Corp (NASDAQ:ARWR) last announced its earnings results on Tuesday, August 12th. The company reported ($0.22) earnings per share for the quarter, meeting the analysts’ consensus estimate of ($0.22). Analysts expect that Arrowhead Research Corp will post $-1.04 EPS for the current fiscal year.

Arrowhead Research Corporation (NASDAQ:ARWR) is a biopharmaceutical company developing targeted RNAi therapeutics.

Receive News & Ratings for Arrowhead Research Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arrowhead Research Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.